Read next
Health
The Weight-Loss Drugs Changed More Than Waistlines
A class of drugs originally for diabetes reshaped obesity treatment and several industries around it.
Health
GLP-1 Class Therapies Restructure Healthcare Equipment and Food Demand
Widespread adoption of anti-obesity medications reshapes operational models across medical devices and consumer goods.
Health
GLP-1 Class Therapies Alter Pharmaceutical Capital Allocation
Surging demand for metabolic treatments is redirecting R&D expenditures away from traditional cardiovascular research.
Health
GLP-1 Supply Constraints Drive Pharmaceutical Capital Expenditure
Drugmakers invest billions in fill-finish contract manufacturing capacity to meet soaring demand for metabolic therapeutics.
Health
AI-Driven Diagnostics Gain Regulatory Approvals for Primary Care Deployment
Health regulatory agencies are accelerating approvals for artificial intelligence diagnostic tools intended for point-of-care clinical use.
Health
Clinical Diagnostics Adopt Rapid Genomic Sequencing to Standardize Treatment
Hospitals are deploying point-of-care genomic analysis to accelerate targeted oncology therapies and reduce diagnostic lead times.